NUVL - Nuvalent gains breakthrough therapy status for non-small cell lung cancer candidate
2024-05-16 16:18:34 ET
More on Nuvalent
- Nuvalent: Pivotal NSCLC Programs Progressing With Additional Data In 2024
- Jefferies starts Nuvalent at buy, cites lung cancer drug candidates
- Nuvalent lung cancer candidate gets FDA breakthrough therapy status
- Seeking Alpha’s Quant Rating on Nuvalent
- Historical earnings data for Nuvalent